Fosun Pharmaceutical bought Concert Pharmaceuticals Concert Pharmaceuticals from 1/19/23

User image

Vladimir Petenev

News editor
press@blackterminal.com

Fosun Pharmaceutical bought Concert Pharmaceuticals for $576 million, or $8 per share.

Concert Pharmaceuticals

Review

Source:

{source} pictogram

ir.concertpharma.com

Vladimir Petenev

News editor

Write your comment first

News feed

Seligdar's revenue in Q1 increased by 66%

4/24/25 SELG

Positive Technologies reported for 3 months of 2025 by IFRS

4/24/25 POSI

Ozon Pharmaceuticals reported for 2024 by IFRS

4/24/25 OZPH

EL5-Energo's power generation in Q1 decreased by 2.9%

4/23/25 ELFV

Alrosa to double investment in Zimbabwe

4/23/25 ALRS

UAE company acquires 16.33% of Russneft

4/23/25 RNFT

Board of Directors of Lenzoloto recommended that dividends be paid for 2024

4/23/25 LNZL

Ozon launched parcel delivery for individuals

4/23/25 OZON

Sollers reported for 2024 by IFRS

4/23/25 SVAV

Super Lenta will open in the locations of the developer A101

4/23/25 LENT